David Tyronne Howton, Jr
2020
Compensation breakdown
| Non-Equity Incentive Plan | $221,625 |
|---|---|
| Option Awards | $3,802,549 |
| Salary | $470,695 |
| Stock Awards | $1,050,929 |
| Other | $157,280 |
| Total | $5,703,078 |
Howton received $3.8M in option awards, accounting for 67% of the total pay in 2020.
Howton also received $221.6K in non-equity incentive plan, $470.7K in salary, $1.1M in stock awards and $157.3K in other compensation.
Rankings
In 2020, David Tyronne Howton, Jr's compensation ranked 1,874th out of 13,090 executives tracked by ExecPay. In other words, Howton earned more than 85.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,874 out of 13,090 | 86th |
Division Manufacturing | 730 out of 5,621 | 87th |
Major group Chemicals And Allied Products | 263 out of 2,254 | 88th |
Industry group Drugs | 221 out of 1,954 | 89th |
Industry Pharmaceutical Preparations | 157 out of 1,459 | 89th |
Pay ratio
| David Tyronne Howton, Jr's Pay | $5,703,078 |
|---|---|
| Median Employee's Pay | $275,247 |
| Pay Ratio | 21to 1 |
In 2020, the annual total compensation of David Tyronne Howton, Jr was $5,703,078.
The annual total compensation of the median employee at Sarepta Therapeutics was $275,247.
The ratio of David Tyronne Howton, Jr's pay to the pay of median employee was therefore 21 to one.
Howton's colleagues
We found seven more compensation records of executives who worked with David Tyronne Howton, Jr at Sarepta Therapeutics in 2020.
2020
Louise Rodino-Klapac
Sarepta Therapeutics
Chief Scientific Officer
2020
Ian Estepan
Sarepta Therapeutics
Chief Financial Officer
2020
Gilmore MMSc
Sarepta Therapeutics
Chief Scientific Officer
2020
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2020
Douglas Ingram
Sarepta Therapeutics
Chief Executive Officer
2020
Joseph Bratica
Sarepta Therapeutics
Vice President, Corporate Controller
2020
William Ciambrone
Sarepta Therapeutics